Precise monitoring of specific biomarkers in biological fluids with accurate biodiagnostic sensors is critical for early diagnosis of diseases and subsequent treatment planning. In this work, we demonstrated an innovative biodiagnostic sensor, PRADA: portable reusable accurate diagnostics with nanostar antennas, for multiplexed biomarker detection in small volumes enabled in a microfluidic platform. Here, PRADA simultaneously detected two biomarkers of myocardial infarction, cardiac troponin I, which is well accepted for cardiac disorders, and neuropeptide Y, which controls cardiac sympathetic drive. We envision low-cost PRADA will have tremendous translational impact and amenable to resource-limited settings for accurate treatment planning in patients.
|